TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) revenue & profit

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): revenue $17.3B, net income $1.4B in 2025; latest quarter -0.8% year over year. From SEC filings.

$17.3BRevenue 2025

TickerTEVA (NYSE)

IndustryHealthcare · Pharmaceutical Preparations

Revenue 2025$17.3B

Net income 2025$1.4B

Net margin8.2%

Annual revenue growth+4.3%

Latest quarter (2026 Q2) · Revenue$4.1B

vs. same quarter last year-0.8%

Latest quarter · Net income-$576M

Annual revenue & net income

Year	Revenue	Net income
2022	$14.9B	-$2.4B
2023	$15.8B	-$559M
2024	$16.5B	-$1.6B
2025	$17.3B	$1.4B

ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.

↗ Official filings on SEC EDGAR

📷 Logo is a trademark of its owner · רונאלדיניו המלך · Public domain · Wikimedia Commons

📷 Raysonho @ Open Grid Scheduler / Scalable Grid Engine · CC0 · Wikimedia Commons

About this data

Figures come from the financial statements U.S.-listed companies file with the Securities and Exchange Commission (SEC EDGAR, XBRL data). We use reported annual and quarterly revenue and net income and compare them with the same period a year earlier to calculate growth.

Companies use different fiscal years and sometimes restate past results, and one-off items can make net income jump. This page is for information only and is not investment advice.